Dr. Sammy Elmariah, MD
Claim this profileMassachusetts General Hospital
Affiliated Hospitals
Massachusetts General Hospital
University Of California, San Francisco
Clinical Trials Sammy Elmariah, MD is currently running
PFO Closure Device
for Preventing Stroke
This study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator education and training and transferability of trial experience to a post-market setting.
Recruiting
1 award
N/A
3 criteria
Proteomics Analysis
for Heart Valve Disease
The purpose of the HALT Biomarkers study are to identify a panel of circulating proteins that discriminates between patients with and without Hypo-Attenuated Leaflet Thickening (HALT) and can be used to supplement the diagnosis of HALT; to characterize changes in circulating proteins after treatment of HALT with systemic anticoagulation; and to identify circulating proteins that predict the occurrence of HALT. The study population will be adult patients undergoing transfemoral transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS) or bioprosthetic valve degeneration. Enrollment will continue until 30 patients with HALT are identified for completion of phase 1. Based on a HALT incidence rate of 10%, we anticipate enrolling 300 patients. Patients are enrolled prior to undergoing transfemoral TAVR. Blood samples, clinical data and echocardiograms will be collected at the following timepoints: baseline (pre-TAVR, T0), post-TAVR (pre-discharge, T1), 30-day follow-up (window 3-9 weeks, T2), and 6-month follow-up (T3). Cardiac 4D CT will be performed at the 30-day follow-up visit to screen for the occurrence of HALT. Patients with HALT will be treated with systemic anticoagulation for 5-6 months, at which point a follow-up CT scan and blood sample will be obtained. Control subjects will also undergo a 6-month study visit with blood sample collection. The study will be conducted within two phases. Phase 1 will serve as a derivation / discovery study in which candidate protein biomarkers of HALT will be identified. Once this is successfully completed, a second cohort will be enrolled within phase 2. Phase 2 will be performed under the auspices a future contract or amendment and will seek to cross-validate the initial study findings.
Recruiting
1 award
Phase 1
3 criteria
More about Sammy Elmariah, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Sammy Elmariah, MD has experience with
- Edwards PASCAL System
- Optimal Medical Therapy
- Decision Aid
- Shared Decision Making Skills Training
- Tendyne Mitral Valve System
- MitraClip System
Breakdown of trials Sammy Elmariah, MD has run
Cardiovascular Disease
Von Willebrand Disease
Mitral Regurgitation
Valvular Heart Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sammy Elmariah, MD specialize in?
Sammy Elmariah, MD focuses on Cardiovascular Disease and Von Willebrand Disease. In particular, much of their work with Cardiovascular Disease has involved treating patients, or patients who are undergoing treatment.
Is Sammy Elmariah, MD currently recruiting for clinical trials?
Yes, Sammy Elmariah, MD is currently recruiting for 5 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Sammy Elmariah, MD has studied deeply?
Yes, Sammy Elmariah, MD has studied treatments such as Edwards PASCAL System, Optimal Medical Therapy, Decision Aid.
What is the best way to schedule an appointment with Sammy Elmariah, MD?
Apply for one of the trials that Sammy Elmariah, MD is conducting.
What is the office address of Sammy Elmariah, MD?
The office of Sammy Elmariah, MD is located at: Massachusetts General Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.